Publications
650
Citations
23,166
Est. group size
~3
Recurring co-author estimate
Active years
29
Publishing since 1998
Kwangsik Nho studies Alzheimer's disease and related forms of cognitive decline, combining genetics, brain imaging, and blood-based markers to identify biological signatures of the disease. Much of the work uses large-scale genomic data (such as polygenic risk scores and genome-wide association studies) alongside measures like liver enzymes, bile acids, and inflammation to predict who will progress toward dementia. The research often examines sex-specific differences in disease risk and resilience.
Publication output has been steady to high across the decade, peaking around 2019 and 2023 with roughly 30-66 papers per year, and averaging about 36 papers annually over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease
Journal of Clinical Medicine · 2026
- ACE inhibition increases Alzheimer’s disease risk by promoting tau phosphorylation
medRxiv · 2025
- Serum BDNF and progression to MCI in cognitively normal older adults: A prospective cohort study
The Journal of Prevention of Alzheimer s Disease · 2025
- Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer’s disease
Frontiers in Aging Neuroscience · 2024
- Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner
Advanced Science · 2023
- Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA
Journal of Clinical Medicine · 2023
- Association of Serum Liver Enzymes with Brain Amyloidopathy and Cognitive Performance
Journal of Alzheimer s Disease Reports · 2023
- Peripheral inflammation is associated with structural brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease
medRxiv · 2023
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding
2023
- Brain regional alternative splicing and clinical traits in Alzheimer’s disease
Alzheimer s & Dementia · 2023
- Implications of serum liver enzymes for brain amyloidopathy and cognition
Research Square · 2023
- Influence of liver function markers and apolipoprotein E ε4 on pathogenesis and cognitive decline in Alzheimer’s disease
Research Square · 2023
- Bile acids inform about a sex‐specific resilience phenotype against Alzheimer’s disease implicating a role for the gut microbiome and the exposome
Alzheimer s & Dementia · 2023
- Implications of Liver Enzymes in the Pathogenesis of Alzheimer’s Disease
Journal of Alzheimer s Disease · 2022
- Interplay of genetic and epigenetic factors in regulating immune‐related pathways in Alzheimer’s disease
Alzheimer s & Dementia · 2022
- Alzheimer s & Dementia×154
- medRxiv×25
- bioRxiv (Cold Spring Harbor Laboratory)×24
- Nature Communications×21
- Scientific Reports×15
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile